1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RANBP3 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA PRR12 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA SRSF3 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA PHF10 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA ARHGDIG CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA NAA16 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA BSN CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA BCLAF1 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA CCAR2 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA CTSA CTRPv2 pan-cancer AAC -0.18 3e-07
Download CSV